4.6 Article

Expression of proteinase-activated receptors (PAR)-2 in articular chondrocytes is modulated by IL-1β, TNF-α and TGF-β

期刊

OSTEOARTHRITIS AND CARTILAGE
卷 14, 期 11, 页码 1163-1173

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.joca.2006.04.015

关键词

proteinase-activated receptor-2; articular chondrocyte; osteoarthritis; IL-1 beta; TNF-alpha; TGF-beta

向作者/读者索取更多资源

Objective: To investigate the modulation of expression of proteinase-activated receptor-2 (PAR-2) in articular chondrocytes by inflammatory cytokines. Design: Articular synovium and cartilage tissues were collected from eight patients with osteoarthritis (OA), and three patients without arthropathy (normal). Chondrocytes were stimulated with interleukin (IL)-1 beta, tumor necrosis factor (TNF)-alpha or transforming growth factor (TGF)-beta 1. The expression of PAR-2 was detected using reverse transcriptase-polymerase chain reaction (PCR), Western blotting and immunofluorescence. Quantitative PCR was performed to assess the expression levels of PAR-2 messenger RNA (mRNA). Results: The expression of PAR-2 mRNA was demonstrated in both OA and normal chondrocytes as well as in synovial fibroblasts. However, the level of PAR-2 in OA chondrocytes was much higher than in normal chondrocytes. Long-term culture revealed that PAR-2 mRNA expression was maintained up to three passages in OA but not in normal chondrocytes. IL-1 beta and TNF-alpha both upregulated PAR-2 expression in normal and OA chondrocytes. In contrast, TGF-beta 1 significantly decreased expression of PAR-2 in OA chondrocytes but increased PAR-2 in normal chondrocytes. Conclusions: Overexpression of PAR-2 in OA chondrocytes is upregulated by proinflammatory cytokines IL-1 beta and TNF-alpha, and down-regulated by regulatory cytokine TGF-beta 1. PAR-2 may be involved in the pathogenesis of OA. (C) 2006 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据